On the contrary, miRNAs 223 and 96 are related to platelet function; miRNA 223 is involved in P2Y12 regulation and, consequently, in the resistance of anti-platelet P2Y12 drugs, and miRNA 96 is involved in platelet granule secretion, suggesting their hypothetical role in regulating antiplatelet drugs in arterial diseases [12,13]. The gene discussed is P2RY12; the disease is arterial disorder.